SADI-S Surgery Explained: What Patients Need to Know

The single anastomosis duodenal switch, known as the SADI-S, is one of the most powerful metabolic and weight-loss operations available today. It was designed to take the traditional duodenal switch, long considered one of the most effective bariatric procedures, and make it simpler, faster, and safer while preserving nearly all of its metabolic power. It does this with one key change: a single intestinal connection instead of two.

This guide explains, in plain language, exactly how the SADI-S works, who it is for, what results to expect, what the real risks are, and how it stacks up against the traditional Roux duodenal switch, gastric bypass, and the sleeve. It is the same information a patient would receive during a thorough informed-consent conversation with a bariatric surgeon.

What Is the SADI-S?

The single anastomosis duodenal switch, sometimes written SADI-S or SADS, was first performed in 2007 by Dr. Andres Sanchez-Pernaute in Madrid. It was created as a streamlined version of the traditional duodenal switch (also called the Roux duodenal switch or BPD-DS), an operation known for producing the greatest weight loss and diabetes remission of any bariatric procedure but historically burdened by a high rate of nutritional complications.

The core idea is simple: keep the metabolic power of the duodenal switch, but replace its two intestinal connections with a single connection. This makes the operation faster, technically simpler, and less prone to certain complications. The SADI-S is endorsed by the International Federation for the Surgery of Obesity (IFSO) and recognized by the American Society for Metabolic and Bariatric Surgery (ASMBS) as a legitimate, mainstream metabolic operation (Ponce de Leon-Ballesteros et al., Obesity Surgery, 2024).

Who Qualifies for the SADI-S?

Current ASMBS and IFSO indications recommend metabolic and bariatric surgery for adults with a body mass index (BMI) of 35 or higher regardless of other conditions, and for those with a BMI of 30 to 35 who have metabolic disease such as type 2 diabetes, high blood pressure, or sleep apnea. For individuals of Asian descent, the threshold is lower, generally a BMI of 27.5 or above (Eisenberg et al., Surgery for Obesity and Related Diseases, 2022).

The SADI-S is particularly well suited to certain groups:

• Patients with very high BMI (50 or above), where simpler operations may not deliver enough durable weight loss.
• Patients with severe or long-standing type 2 diabetes, especially those requiring insulin, because of the operation's strong metabolic effect.
• Patients with weight regain or inadequate weight loss after a prior sleeve gastrectomy. Because the first step of the SADI-S is itself a sleeve, the operation can be performed as a planned or revisional second stage after a sleeve.

Before surgery, every patient goes through a full evaluation including nutrition counseling, a psychological assessment, blood work, and sometimes an upper endoscopy. This is not a bureaucratic hurdle. It is how the surgical team confirms safety and selects the operation that fits the individual best.

How the SADI-S Is Performed and How It Differs From the Roux Duodenal Switch

Both the SADI-S and the traditional Roux duodenal switch begin identically. The difference is entirely in how the intestine is rearranged. The operation is performed laparoscopically or robotically through five or six small incisions.

Step one, the sleeve gastrectomy (identical in both operations). About 75 to 85 percent of the stomach is removed, including the fundus, the part of the stomach that produces most of the hunger hormone ghrelin. What remains is a narrow, banana-shaped stomach tube. Crucially, the pylorus, the muscular valve at the bottom of the stomach, is preserved. This natural valve controls how the stomach empties and helps prevent dumping syndrome.

Step two, dividing the duodenum (identical in both operations). The first part of the small intestine, the duodenum, is divided about two to three centimeters below the pylorus.

Step three, the intestinal reconstruction (this is where the two operations diverge).

• In the traditional Roux duodenal switch, the intestine is divided and rebuilt into a Roux-en-Y configuration with two separate intestinal connections. This produces three distinct channels: an alimentary limb carrying food, a biliopancreatic limb carrying digestive juices, and a short common channel, typically 100 to 150 centimeters, where the two finally meet.
• In the SADI-S, all of that complexity is avoided. The surgeon measures back 250 to 300 centimeters from the end of the small intestine (the ileocecal valve), brings that single loop of ileum up, and connects it directly to the divided duodenum. One loop. One connection. One anastomosis.

The longer common channel in the SADI-S (250 to 300 centimeters versus 100 to 150 in the Roux DS) is deliberate. It compensates for eliminating the separate alimentary limb and reduces the risk of severe malabsorption and protein deficiency. Some surgeons now individualize the common channel length based on each patient's total measured bowel length, an approach shown to reduce reoperations and late complications (Fair et al., Surgical Endoscopy, 2023).

The practical results of this simpler design are a shorter operative time (roughly 60 to 120 minutes versus 90 to 150 for the Roux DS), one fewer anastomosis, one fewer mesenteric defect, and anatomy that is easier to study and revise later. Most patients stay one to two nights in the hospital and return to normal activities within two to four weeks.

How the SADI-S Works

The SADI-S produces weight loss and metabolic improvement through three mechanisms working together: restriction, hormonal reprogramming, and malabsorption.

• Restriction. The sleeve limits how much food can be eaten at one time.
• Hormonal reprogramming. Removing the fundus sharply reduces ghrelin, the hunger hormone. At the same time, delivering food rapidly to the far end of the small intestine triggers a large surge in the satiety hormones GLP-1 and PYY. These hormonal shifts also improve insulin secretion and sensitivity, often within days of surgery and well before major weight loss occurs. This is a key reason the SADI-S achieves such strong diabetes remission.
• Malabsorption. Because food and digestive enzymes share a common channel of only 250 to 300 centimeters, the body absorbs fewer calories and less fat. Because that channel is longer than in the Roux DS, the malabsorption is somewhat less extreme, a deliberate trade-off that reduces nutritional complications.

Results: Weight Loss and Metabolic Improvement

Weight loss. Patients typically lose 34 to 40 percent of total body weight, or roughly 70 to 88 percent of excess weight. Long-term data from the originating Madrid center show excess weight loss of about 87 percent at 5 years and 80 percent at 10 years. A 10-year multicenter comparative study found that maximum total weight loss was essentially the same for the SADI-S and the traditional duodenal switch, around 47 percent versus 46 percent (El Ghazal et al., Surgical Endoscopy, 2025).

Diabetes remission. Type 2 diabetes remission generally ranges from about 60 to over 90 percent, among the highest of any bariatric operation. In the Madrid series, of 41 patients who required insulin before surgery, only 7 still needed it at 5 years. Meta-analysis data show the SADI-S achieves significantly greater diabetes remission than Roux-en-Y gastric bypass (Sabatella et al., Obesity Surgery, 2025). Blood pressure improves in roughly 59 to 85 percent of patients, and sleep apnea resolves in about 61 to 89 percent.

Durability and regain. Some weight regain after reaching the lowest weight is normal and expected. The SADI-S shows durable maintenance overall, with excess weight loss declining only modestly from about 87 percent at 5 years to 80 percent at 10 years. An estimated 3 to 6 percent of patients may eventually need revisional surgery for insufficient weight loss. As with every bariatric procedure, the operation changes anatomy, hormones, and metabolism, but not habits. Long-term success still depends on the patient.

Risks and Complications

The SADI-S was specifically designed to reduce the complication burden of the traditional duodenal switch, and the safety data are reassuring. Reported mortality ranges from about 0.03 to 0.5 percent; the originating center reported zero deaths in 164 patients over 10 years.

Early complications include leak (roughly 0.6 to 2.2 percent), bleeding (1 to 2 percent), and blood clots. The overall 30-day complication rate is reported at about 3.3 to 11.6 percent.

Nutritional deficiencies are the most important long-term concern, but they are less severe than after the traditional Roux duodenal switch. In one 10-year comparative cohort, nutritional complications occurred in about 16 percent of SADI-S patients versus about 54 percent of Roux DS patients (El Ghazal et al., Surgical Endoscopy, 2025). It is worth noting that a randomized trial and other cohorts have found the difference between the two operations smaller or less clear-cut, so the consistent message across the literature is that the SADI-S tends toward fewer nutritional problems than the Roux DS, rather than a fixed numeric gap (Axer et al., Obesity Surgery, 2026). Protein malnutrition, the most serious deficiency, affects roughly 1 to 6 percent of patients. Fat-soluble vitamin deficiencies require ongoing monitoring, and loose stools or diarrhea are common early, with 25 to 30 percent still reporting loose stools beyond 3 years.

Bile reflux and GERD. GERD symptoms occur in roughly 4 to 30 percent of patients. Clinically significant bile reflux, the main theoretical concern with a loop configuration, affects about 1 to 7.5 percent. When it becomes problematic, the SADI-S can be converted to a Roux duodenal switch to divert bile away.

Marginal ulcers and internal hernias. Both are rare after the SADI-S. Marginal ulcers are uncommon in part because the pylorus is preserved, a notable advantage over gastric bypass. Internal hernias are also rare because there is only one mesenteric defect.

SADI-S Compared With Other Bariatric Procedures

• SADI-S vs. Roux duodenal switch (BPD-DS): Similar weight loss and diabetes remission. Trade-offs: the SADI-S is faster and simpler with a tendency toward fewer nutritional complications; the Roux DS greatly reduces bile reflux risk and may hold a slight edge in very long-term weight maintenance.
• SADI-S vs. Roux-en-Y gastric bypass: The SADI-S produces greater weight loss and higher diabetes remission, with far fewer marginal ulcers and dumping episodes. Trade-offs: the SADI-S requires more intensive nutritional monitoring and lifelong supplementation.
• SADI-S vs. sleeve gastrectomy: The SADI-S produces significantly more weight loss and much higher diabetes remission. Trade-offs: the sleeve is simpler, with fewer complications and lighter supplement requirements.

Choosing the right operation is highly individualized. BMI, the severity and duration of diabetes, prior surgeries, reflux status, anatomy, and personal goals all factor into the decision, which is best made together with an experienced bariatric surgeon.

Life After the SADI-S

Recovery and long-term maintenance follow a predictable structure, but the nutritional demands of the SADI-S are higher than those of a sleeve or standard bypass because of the malabsorptive component.

• Diet progression. Diet advances in stages: clear liquids, then purees, then soft foods, and finally regular food by about six to eight weeks.
• Protein. Protein comes first at every meal, with a target of at least 80 to 100 grams per day, higher than after a sleeve or bypass.
• Vitamins and supplements (lifelong and non-negotiable). These include a bariatric multivitamin containing fat-soluble vitamins, calcium citrate (roughly 1,800 to 2,400 mg per day), high-dose vitamin D, vitamin A, iron, zinc, vitamin B12, folic acid, and copper.
• Lab monitoring. Blood work every three to six months during the first year, then at least annually for life.
• Activity. Build to at least 150 minutes of exercise per week.

The importance of supplementation and follow-up cannot be overstated. Stopping vitamins or dropping out of monitoring puts patients at real risk of serious and sometimes irreversible nutritional complications. With a disciplined protocol, outcomes are excellent; one center reported zero nutritional deficiencies at 4 years using a dedicated supplementation and monitoring program. In one large series, more than 82 percent of patients said they would choose the procedure again.

If you are considering SADI-S in South Florida, or plan to travel to Miami for it, our SADI-S surgery in Miami page covers consultation, surgery and aftercare at our practice.

Frequently Asked Questions

What is the difference between the SADI-S and the traditional duodenal switch?

Both start with the same sleeve gastrectomy and duodenal division. The difference is the intestinal reconstruction. The traditional Roux duodenal switch uses two intestinal connections and three channels; the SADI-S uses a single connection and a single, longer common channel. The result is a faster, simpler operation with a tendency toward fewer nutritional complications, at the cost of a small risk of bile reflux (Ponce de Leon-Ballesteros et al., Obesity Surgery, 2024).

How much weight will I lose with the SADI-S?

Most patients lose about 34 to 40 percent of their total body weight, or roughly 70 to 88 percent of excess weight, with long-term data showing about 80 percent excess weight loss maintained at 10 years (El Ghazal et al., Surgical Endoscopy, 2025).

Is the SADI-S better than gastric bypass for diabetes?

For many patients with severe or insulin-dependent type 2 diabetes, yes. A 2025 randomized trial found the SADI-S produced greater weight loss than gastric bypass at 2 years, and meta-analyses show higher diabetes remission with the SADI-S, though it requires closer nutritional monitoring (Robert et al., The Lancet, 2025; Sabatella et al., Obesity Surgery, 2025).

Can the SADI-S be done after I have already had a sleeve gastrectomy?

Yes. Because the sleeve is the first step of the SADI-S, the operation is well suited as a planned or revisional second stage for patients who have inadequate weight loss or weight regain after a sleeve.

What happens if I develop bile reflux after the SADI-S?

Clinically significant bile reflux is uncommon (about 1 to 7.5 percent). If it becomes a problem that does not respond to medical management, the SADI-S can be converted to a Roux duodenal switch, which diverts bile away from the stomach and esophagus.

Do I really need to take vitamins for the rest of my life?

Yes. Lifelong vitamins, supplements, and regular lab monitoring are the most important commitment after this surgery. Because of the malabsorptive component, skipping them risks serious and sometimes permanent nutritional deficiencies. With consistent supplementation and follow-up, these complications are largely preventable.

The Bottom Line

The SADI-S builds on one of the most powerful bariatric operations and makes it simpler, faster, and safer while preserving its metabolic power. It delivers excellent weight loss, outstanding diabetes remission, and major improvements in metabolic disease, with fewer nutritional complications than the traditional Roux duodenal switch. The trade-off is a small risk of bile reflux and a lifelong commitment to vitamins, labs, and follow-up. For the right patient, especially one with very high BMI or severe diabetes, it is among the most effective operations medicine can offer.

If you are considering weight-loss surgery, the next step is a consultation to review your individual situation and determine whether the SADI-S, the traditional duodenal switch, or another procedure is the best fit for you.